C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/24 (2006.01) A61K 38/20 (2006.01) C07K 14/715 (2006.01) C12N 15/12 (2006.01) C12Q 1/02 (2006.01) C12Q 1/68 (2006.01)
Patent
CA 2689842
This invention relates to the diagnosis, treatment and methods for discovery of new therapeutics for atopic asthma and related disorders based on variants of Asthma Associated Factor (2). One embodiment of the invention is a variant of AAF2, wherein codon 173 is deleted resulting in the loss of glutamine 173 from the mature protein precursor. This single amino acid deletion results in a non-functional AAF2 protein and therefore the presence of this phenotype should be associated with less evidence of atopic asthma. Correspondingly, the lack of susceptibility to an asthmatic, atopic phenotype is characterized by the loss of glutamine at codon 173. The invention includes isolated DNA molecules which are variants of the wild type sequence as well as the proteins encoded by such DNA and the use of such DNA molecules and expressed protein in the diagnosis and treatment of atopic asthma.
Grasso Luigi
Holroyd Kenneth J.
Levitt Roy Clifford
Nicolaides Nicholas C.
Deeth Williams Wall Llp
Genaera Corporation
LandOfFree
Il-9 receptor variants, useful in treating and diagnosing... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Il-9 receptor variants, useful in treating and diagnosing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Il-9 receptor variants, useful in treating and diagnosing... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1438099